This study will determine the effectiveness of clozapine versus olanzapine in treating people with schizophrenia that has not improved with treatment.
This is a two-year open-label, randomized trial of the comparative effectiveness of clozapine versus olanzapine in patients with treatment refractory schizophrenia. The objective is to determine whether in a naturalistic setting olanzapine is a logical treatment choice (before using the more toxic clozapine) for some treatment refractory patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
38
Commonwealth Research Center
Jamaica Plain, Massachusetts, United States
Changes in quality of life.
Symptom measures, neurological side effects, neuropsychological performance, patient satisfaction and burden on the family.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.